Literature DB >> 15606725

Determinants of augmentation index in young men: the ARYA study.

M J C A van Trijp1, W J W Bos, C S P M Uiterwaal, A Oren, L E Vos, D E Grobbee, M L Bots.   

Abstract

BACKGROUND: There is an increasing interest in the augmentation index (AIx), the proportion of the central pulse pressure resulting from peripheral arterial wave reflection, which has been related to cardiovascular disease risk and mortality. Most of the data on the AIx have been collected in patients with established cardiovascular disease. In contrast, data in the young are scarce. However, as AIx might be used to evaluate cardiovascular disease risk already at an early age, we aimed to study determinants of AIx in a population of healthy young men.
MATERIALS AND METHODS: Three hundred and thirty males (mean age of 28 years) of the Atherosclerosis Risk in Young Adults study (ARYA-study) were studied in this cross sectional, population-based study. Anthropometrics and risk factors for cardiovascular disease were determined and AIx was estimated by radial applanation tonometry. The data were analysed using linear regression models.
RESULTS: Augmentation index was associated with age, height (inverse), heart rate (inverse) and mean arterial pressure (positive). After adjustment for these determinants, smoking (beta = 0.31%/pack years, 95% CI [0.06; 0.55]) and LDL-cholesterol (beta = 1.28%/(mmol L(-1)), 95% CI [0.04; 2.51]) were statistically significant related to AIx.
CONCLUSIONS: This study among young adult males shows that smoking and LDL-cholesterol are positively related to AIx. These findings support the view that AIx may be used as a marker for early vascular damage and cardiovascular disease risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606725     DOI: 10.1111/j.1365-2362.2004.01433.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.

Authors:  Kevin S Heffernan; Jeffrey T Kuvin; Mark J Sarnak; Ronald D Perrone; Dana C Miskulin; Darya Rudym; Priya Chandra; Richard H Karas; Vandana Menon
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

2.  Smoking Behaviors and Arterial Stiffness Measured by Pulse Wave Velocity in Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ricky Camplain; Michelle L Meyer; Hirofumi Tanaka; Priya Palta; Sunil K Agarwal; David Aguilar; Kenneth R Butler; Gerardo Heiss
Journal:  Am J Hypertens       Date:  2015-12-10       Impact factor: 2.689

3.  Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.

Authors:  Ulrich Fischer-Rasokat; Jörg Honold; Denise Lochmann; Christoph Liebetrau; Jürgen Leick; Christian Hamm; Stephan Fichtlscherer; Helge Möllmann; Ioakim Spyridopoulos
Journal:  Clin Res Cardiol       Date:  2014-02-18       Impact factor: 5.460

4.  Limitations of augmentation index in the assessment of wave reflection in normotensive healthy individuals.

Authors:  Alun D Hughes; Chloe Park; Justin Davies; Darrel Francis; Simon A McG Thom; Jamil Mayet; Kim H Parker
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

5.  Structural and functional remodeling of the female Apoe-/- mouse aorta due to chronic cigarette smoke exposure.

Authors:  Yasmeen M Farra; Jacqueline Matz; Bhama Ramkhelawon; Jessica M Oakes; Chiara Bellini
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-09       Impact factor: 5.125

6.  Characterization of arterial wave reflection in healthy bonnet macaques: feasibility of applanation tonometry.

Authors:  Jason Lazar; Ghazanfar Qureshi; Haroon Kamran; Leonard A Rosenblum; John G Kral; Louis Salciccioli
Journal:  J Biomed Biotechnol       Date:  2009-03-10

Review 7.  "Smooth Muscle Cell Stiffness Syndrome"-Revisiting the Structural Basis of Arterial Stiffness.

Authors:  Nancy L Sehgel; Stephen F Vatner; Gerald A Meininger
Journal:  Front Physiol       Date:  2015-11-18       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.